Pulmonary Embolism
📧 Sign up to get email alerts when something new happens for Pulmonary Embolism.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-12-11FDA Approved: ENOXAPARIN SODIUM — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approves a Supplemental Application for enoxaparin sodium from Sanofi-Aventis U.S. LLC to update the product labeling.
-
FDA approval · 2018-11-14FDA Approved: FONDAPARINUX SODIUM — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approves the Original Application for fondaparinux sodium from Zydus Pharmaceuticals (USA) Inc., a generic anticoagulant.
-
CLINICAL_TRIALS trial_result · 2018-10-24Clinical Trial Update: Cancer Venous Thromboembolism (VTE) [Phase 3]
Phase 3 clinical trial update for cancer-associated venous thromboembolism (VTE) completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-18Clinical Trial Update: Post-marketing Study of Monteplase ("Cleactor") in Patients With Acute Pulmonary Embolism [Phase 4]
Post-marketing Phase 4 trial update for Monteplase (Cleactor) in patients with acute pulmonary embolism completed.
-
CLINICAL_TRIALS trial_result · 2018-09-27Clinical Trial Update: XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis [Phase 4]
Phase 4 clinical trial of rivaroxaban for pulmonary embolism managed with catheter-directed thrombolysis; study terminated with results post…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery [Phase 1, Phase 2]
Phase 1/2 trial update on extended low-molecular-weight heparin for VTE prophylaxis in thoracic surgery shows completed status; assesses pre…
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Electronic Support for Pulmonary Embolism Emergency Disposition [NA]
A Kaiser Permanente trial evaluating electronic support for emergency disposition in pulmonary embolism has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-24Clinical Trial Update: A Different Approach to Preventing Thrombosis [Phase 3]
Phase 3 clinical trial update on a new approach to preventing thrombosis; results are posted for completed study.
-
CLINICAL_TRIALS other · 2018-07-24Clinical Trial Update: Catheter Directed Interventions in Pulmonary Embolism [NA]
The update concerns catheter-directed interventions for pulmonary embolism, sponsored by Assiut University. The current status of the trial …
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Determine the Frequency of a HTPPE in 5 Years (± on 1 Year) After a First Episode of Idiopathic Pulmonary Embolism. [NA]
This clinical trial update indicates that the study evaluating the frequency of HTPPE within five years after a first idiopathic pulmonary e…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Analysis of a Training Intervention for Pulmonary Embolism Diagnosis in Emergency Department (APEED) [NA]
This document reports the completion of a clinical study analyzing a training intervention intended to improve emergency department diagnosi…
-
CLINICAL_TRIALS research · 2018-06-12Clinical Trial Update: Genetic Determinants of Warfarin Anticoagulation Effect [NA]
This clinical trial update discusses genetic determinants of warfarin's anticoagulation effect in patients with venous thrombosis, pulmonary…
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Evaluation of the Technical Success of IVUS Guided VCF Placement Using the LUMIFI™ With Crux® VCF System [NA]
A terminated clinical trial evaluating the technical success of IVUS guided VCF placement using the LUMIFI with Crux VCF System; results pos…
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: Assessment of the Impact of TIP Score on Thromboprophylaxis in Patients With Non-surgical Lower Leg Trauma.
This trial update reports results from a completed study assessing how the TIP score affects thromboprophylaxis decisions in patients with n…
-
CLINICAL_TRIALS withdrawal · 2018-05-31Clinical Trial Update: Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients [Phase 4]
The Phase 4 trial evaluating the safety of topical tranexamic acid in high-risk total joint arthroplasty patients was withdrawn. The safety …
-
CLINICAL_TRIALS research · 2018-05-25Clinical Trial Update: A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa
This clinical trial update describes a survey of hospitalizations in cardiology units across Sub-Saharan Africa. The study covers various ca…
-
CLINICAL_TRIALS research · 2018-05-22Clinical Trial Update: Use of Bedside Ultrasound in Emergency Department Patients With Concern for Pulmonary Embolism to Reduce CT Imaging [NA]
This clinical trial update describes a study evaluating bedside ultrasound in emergency department patients with suspected pulmonary embolis…
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study
A completed multicenter outcome study evaluating methods to rule out pulmonary embolism during pregnancy and reporting patient outcomes.
-
CLINICAL_TRIALS trial_result · 2018-04-20Clinical Trial Update: A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department [Phase 4]
Phase 4 trial evaluating rivaroxaban for early discharge of low-risk pulmonary embolism patients from the emergency department, with results…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Nitric Oxide to Treat Pulmonary Embolism [Phase 2]
Phase 2 clinical trial evaluating nitric oxide for the treatment of pulmonary embolism has been completed with results posted
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism [Phase 4]
Phase 4 trial comparing thrombolytic therapy with anticoagulation in submassive pulmonary embolism has completed.
-
FDA approval · 2017-12-26FDA Approved: FONDAPARINUX SODIUM — Original Application (Eugia US LLC)
FDA approved a generic version of fondaparinux sodium (Eugia US LLC) through an Original ANDA, enabling use of this anticoagulant for preven…
-
CLINICAL_TRIALS trial_result · 2017-12-19Clinical Trial Update: Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) [Phase 3]
Phase 3 trial evaluating reduced-dose rivaroxaban for long-term prevention of recurrent symptomatic venous thromboembolism following an init…
-
FDA approval · 2017-11-30FDA Approved: HEPARIN SODIUM — Original Application (Mylan Institutional LLC)
FDA approved an Original Application for HEPARIN SODIUM (generic) from Mylan Institutional LLC, authorizing marketing of this anticoagulant.…
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease [Phase 4]
Phase 4 clinical trial evaluating the safety of low-dose intravenous contrast CT scanning in chronic kidney disease has completed.